Experience with phenylethylbiguanide (DBI) tablets and timed-disintegration capsules (DBI-TD) administered as an adjunct to insulin or sulfonylurea drugs in previously treated diabetic patients.
{"title":"Experience with phenylethylbiguanide (DBI) tablets and timed-disintegration capsules (DBI-TD) administered as an adjunct to insulin or sulfonylurea drugs in previously treated diabetic patients.","authors":"T Jakobson, A Kahanpää, B Berglund","doi":"","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":7919,"journal":{"name":"Annales medicinae internae Fenniae","volume":"54 3","pages":"109-16"},"PeriodicalIF":0.0000,"publicationDate":"1965-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annales medicinae internae Fenniae","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}